HRP20020696A2 - 3-aminoquinazolin-2,4-dione antibakterial agents - Google Patents

3-aminoquinazolin-2,4-dione antibakterial agents Download PDF

Info

Publication number
HRP20020696A2
HRP20020696A2 HR20020696A HRP20020696A HRP20020696A2 HR P20020696 A2 HRP20020696 A2 HR P20020696A2 HR 20020696 A HR20020696 A HR 20020696A HR P20020696 A HRP20020696 A HR P20020696A HR P20020696 A2 HRP20020696 A2 HR P20020696A2
Authority
HR
Croatia
Prior art keywords
amino
cyclopropyl
dione
fluoro
quinazoline
Prior art date
Application number
HR20020696A
Other languages
English (en)
Croatian (hr)
Inventor
Paul Bird
Edmund Lee Ellsworth
Dai Quoc Nguyen
Joseph Peter Sanchez
Howard Daniel Hollis Showalter
Rajeshwar Singh
Michael Andrew Stier
Tuan Phong Tran
Brian Morgan Watson
Judy Yip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HRP20020696A2 publication Critical patent/HRP20020696A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Paper (AREA)
HR20020696A 2000-01-24 2002-08-23 3-aminoquinazolin-2,4-dione antibakterial agents HRP20020696A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18

Publications (1)

Publication Number Publication Date
HRP20020696A2 true HRP20020696A2 (en) 2003-12-31

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020696A HRP20020696A2 (en) 2000-01-24 2002-08-23 3-aminoquinazolin-2,4-dione antibakterial agents

Country Status (38)

Country Link
US (2) US7094780B1 (no)
EP (1) EP1255739B1 (no)
JP (1) JP4811978B2 (no)
KR (1) KR20020067701A (no)
CN (1) CN1425008A (no)
AP (1) AP2002002603A0 (no)
AR (1) AR030186A1 (no)
AT (1) ATE398110T1 (no)
AU (1) AU783078B2 (no)
BG (1) BG107023A (no)
BR (1) BR0017010A (no)
CA (1) CA2393802C (no)
CO (1) CO5320600A1 (no)
CR (1) CR6709A (no)
DE (1) DE60039194D1 (no)
EA (1) EA005585B1 (no)
EE (1) EE200200412A (no)
ES (1) ES2304992T3 (no)
GE (1) GEP20053429B (no)
HK (1) HK1054237A1 (no)
HN (1) HN2001000009A (no)
HR (1) HRP20020696A2 (no)
HU (1) HUP0204101A3 (no)
IL (1) IL150393A0 (no)
IS (1) IS6448A (no)
MA (1) MA26866A1 (no)
MX (1) MXPA02005989A (no)
NO (1) NO20023516D0 (no)
OA (1) OA12316A (no)
PA (1) PA8510101A1 (no)
PE (1) PE20011060A1 (no)
PL (1) PL356837A1 (no)
SK (1) SK10572002A3 (no)
SV (1) SV2001000288A (no)
TN (1) TNSN01011A1 (no)
UY (1) UY26551A1 (no)
WO (1) WO2001053273A1 (no)
YU (1) YU55902A (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812644B1 (pt) 1997-09-15 2010-07-13 quinolonas antimicrobianas, composição farmacêutica e uso das mesmas.
MXPA03010799A (es) 2001-05-30 2005-07-25 Warner Lambert Co Agentes antibacterianos.
BR0210028A (pt) * 2001-06-19 2004-06-22 Warner Lambert Co Agentes antibacterianos
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
BRPI0414319A (pt) * 2003-09-12 2006-11-07 Warner Lambert Co agentes antibacterianos de quinolona
JP2007511597A (ja) * 2003-11-18 2007-05-10 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌アミノキナゾリヂンヂオン誘導体
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
ATE447572T1 (de) * 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
EP1999125A2 (en) 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
ATE507219T1 (de) 2006-03-28 2011-05-15 Warner Chilcott Co Llc Malatsalze und polymorphe von (3s,5s)-7-ä3-amino- 5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro 8-methoxy-4-oxo-3-chinolincarbonsäure
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
PL2239257T3 (pl) * 2008-01-30 2012-10-31 Shin Poong Pharmaceutical Co Ltd Nowe pochodne chinazolino-2,4-dionu oraz zawierające je farmaceutyczne kompozycje do profilaktyki i leczenia chorób nerwów czaszkowych
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
KR102132574B1 (ko) 2011-03-15 2020-07-09 로렌스 리버모어 내쇼날 시큐리티, 엘엘시 트라이사이클릭 자이라제 억제제
RS57621B1 (sr) * 2011-12-21 2018-11-30 Jiangsu Hengrui Medicine Co Derivat šestočlanog heteroaril prstena pirola, postupak njegove pripreme i njegova medicinska upotreba
SG10201610416TA (en) 2012-06-13 2017-01-27 Incyte Corp Substituted tricyclic compounds as fgfr inhibitors
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
EP2895488A1 (en) 2012-09-12 2015-07-22 Trius Therapeutics, Inc. Tricyclic gyrase inhibitors for use as antibacterial agents
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
SI2986610T1 (en) 2013-04-19 2018-04-30 Incyte Holdings Corporation Bicyclic heterocycles as inhibitors of FGFR
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MX2020004108A (es) 2015-02-20 2022-01-03 Incyte Corp Heterociclos biciclicos como inhibidores de receptores del factor de crecimiento fibroblastico (fgfr).
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
WO2019213544A2 (en) 2018-05-04 2019-11-07 Incyte Corporation Solid forms of an fgfr inhibitor and processes for preparing the same
TW201946630A (zh) 2018-05-04 2019-12-16 美商英塞特公司 Fgfr抑制劑之鹽
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
IL291901A (en) 2019-10-14 2022-06-01 Incyte Corp Bicyclyl heterocycles as fgr suppressors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021113462A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (no) * 1959-11-05
NL80851C (no) * 1958-02-25 1956-03-15
ATE8626T1 (de) 1980-03-10 1984-08-15 Berri-Balzac Societe Dite: 3-amino-(1h,3h)-2,4-chinazolindionderivate.
GB2097784A (en) 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
AU5813394A (en) 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
AU6908398A (en) 1996-10-28 1998-05-22 Versicor Inc Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones
US6331538B1 (en) * 1997-10-28 2001-12-18 Warner-Lambert Company 7-substituted quinazolin-2,4-diones useful as antibacterial agents
EP1080092B1 (en) 1998-05-26 2008-07-23 Warner-Lambert Company LLC Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
WO2000035885A1 (en) * 1998-12-11 2000-06-22 F. Hoffmann-La Roche Ag Cyclic hydrazine derivatives as tnf-alpha inhibitors

Also Published As

Publication number Publication date
CA2393802C (en) 2011-04-19
CO5320600A1 (es) 2003-09-30
ATE398110T1 (de) 2008-07-15
EA005585B1 (ru) 2005-04-28
US20060183762A1 (en) 2006-08-17
HUP0204101A2 (hu) 2003-04-28
IS6448A (is) 2002-06-27
JP2003520277A (ja) 2003-07-02
HK1054237A1 (zh) 2003-11-21
PE20011060A1 (es) 2001-10-12
PL356837A1 (en) 2004-07-12
NO20023516L (no) 2002-07-23
AR030186A1 (es) 2003-08-13
MA26866A1 (fr) 2004-12-20
HUP0204101A3 (en) 2004-05-28
YU55902A (sh) 2006-01-16
EP1255739A1 (en) 2002-11-13
US7582627B2 (en) 2009-09-01
IL150393A0 (en) 2002-12-01
OA12316A (en) 2006-05-15
SV2001000288A (es) 2001-11-30
AU783078B2 (en) 2005-09-22
CA2393802A1 (en) 2001-07-26
GEP20053429B (en) 2005-01-25
EA200200661A1 (ru) 2003-02-27
US7094780B1 (en) 2006-08-22
PA8510101A1 (es) 2003-06-30
KR20020067701A (ko) 2002-08-23
EE200200412A (et) 2003-10-15
BG107023A (en) 2003-04-30
CR6709A (es) 2003-11-25
NO20023516D0 (no) 2002-07-23
EP1255739B1 (en) 2008-06-11
CN1425008A (zh) 2003-06-18
HN2001000009A (es) 2001-06-13
WO2001053273A1 (en) 2001-07-26
DE60039194D1 (de) 2008-07-24
SK10572002A3 (sk) 2003-10-07
ES2304992T3 (es) 2008-11-01
AU2089901A (en) 2001-07-31
US20060287308A1 (en) 2006-12-21
TNSN01011A1 (en) 2005-11-10
UY26551A1 (es) 2001-04-30
AP2002002603A0 (en) 2002-09-30
JP4811978B2 (ja) 2011-11-09
BR0017010A (pt) 2002-11-05
MXPA02005989A (es) 2002-10-23

Similar Documents

Publication Publication Date Title
EP1255739B1 (en) 3-aminoquinazolin-2,4-dione antibacterial agents
DE69814135T2 (de) 7-substituierte chinazolin-2,4-dionen verwendbar als antibakterielle mittel
EP0172651B1 (en) Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acids; substituted-5-amino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
HU196986B (en) Process for producing new naphtiridine- and quinoline-carboxylic acids of antibacterial activity and pharmaceutical compositions containing them
EP3080131A1 (en) Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
EP3541817B1 (en) Imidazopyridazine modulators of il-12, il-23 and/or ifn-alpha
JPH0819099B2 (ja) アザビシクロキノロンカルボン酸化合物製造用中間体
US20180222904A1 (en) Bruton's tyrosine kinase inhibitors
JPH06508366A (ja) イミダゾ〔1,5−a〕キノキサリン
JP2002533465A (ja) Xa因子阻害剤としての窒素を含む複素二環類
JPH0755945B2 (ja) 抗菌剤
US4771055A (en) 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
EP0362759A1 (en) Pyridonecarboxylic acids
US20030114666A1 (en) Antibacterial agents
EP0347851B1 (en) Quinolonecarboxylic acids
JPH037260A (ja) 新規キノロン誘導体またはその塩及びこれを含有する抗菌剤
CN112079836A (zh) ***并嘧啶类化合物及其盐、组合物和应用

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn